A significant advance in cancer investigation is emerging with the use of mini-antibodies to restore mutated p53. This essential malignant suppressor protein is frequently disabled in many types of cancer, leading https://bookmarkquotes.com/story22090800/mini-antibodies-revive-tumor-suppressor-p53-a-potential-pathway-for-malignant-management